U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT06932861) titled 'Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma' on April 10.
Brief Summary: An Exploratory Study on the Use of mRNA Tumor Vaccines in the Treatment of Refractory Rhabdomyosarcoma
Study Start Date: May 01
Study Type: INTERVENTIONAL
Condition:
Rhabdomyosarcoma
Intervention:
BIOLOGICAL: mRNA Tumor Vaccine Therapy
personalized mRNA vaccines
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Xinxin Zhang
Information provided by (Responsible Party): Xinxin Zhang, Chinese PLA General Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....